| Mrs Margo Suzanne Towne, MS,CCC-SLP | |
|
1095 Pingree Rd Ste 119, Crystal Lake, IL 60014-1726 | |
| (847) 458-8889 | |
| Not Available |
| Full Name | Mrs Margo Suzanne Towne |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1095 Pingree Rd Ste 119, Crystal Lake, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063668754 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146.007850 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Margo Suzanne Towne, MS,CCC-SLP 5498 Danbury Circle, Lake In The Hills, IL 60156 Ph: (815) 459-3810 | Mrs Margo Suzanne Towne, MS,CCC-SLP 1095 Pingree Rd Ste 119, Crystal Lake, IL 60014-1726 Ph: (847) 458-8889 |
News Archive
A drug commonly used for the prevention of allergies and asthma someday could find new use in preventing liver disease and reducing the need for transplants, according to new research published in the October 2016 edition of the scientific journal Hepatology.
Protein Metrics, Inc., a leading provider of software for rapid and thorough protein and peptide characterization, today announced the release of a freeware version of their Preview™ software for pre-search protein analysis available for download from the company's website.
Extending federal employee health insurance and retirement survivor benefits to same-sex domestic partners would have a relatively small impact on the number of people covered and on the cost of those programs, according to an analysis done for Congress.
Researchers in the United States have demonstrated the effectiveness of early treatment with REGEN-COV™ at preventing symptomatic disease among people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
In a pivotal Phase III study led by researchers at The University of Texas MD Anderson Cancer Center, the oral anti-angiogenic therapy lenvatinib has shown dramatic improvement in progression-free survival in patients with advanced radioiodine-refractory thyroid cancer.
› Verified 3 days ago
Jaclyn Nicole Buhs, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Commerce Dr, Crystal Lake, IL 60014 Phone: 708-699-9569 | |
Diana Smithana, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1451 Magnolia Dr, Crystal Lake, IL 60014 Phone: 815-355-4064 | |
Heather Geeves Wright, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 W Woodstock St, Crystal Lake, IL 60014 Phone: 815-703-9058 | |
Mrs. Cindy Lynn Brackett, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3906 Tecoma Dr, Crystal Lake, IL 60012 Phone: 815-546-5822 | |
Mrs. Stephanie Lyn Schoof, M.S. CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1095 Pingree Rd, Suite 119, Crystal Lake, IL 60014 Phone: 847-458-8890 Fax: 847-458-8889 | |
Mrs. Kaitlan O Finn, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 411 E Congress Pkwy, Suite B, Crystal Lake, IL 60014 Phone: 815-459-3810 Fax: 815-356-3550 |